IL143862A0 - Human akt-3 - Google Patents

Human akt-3

Info

Publication number
IL143862A0
IL143862A0 IL14386299A IL14386299A IL143862A0 IL 143862 A0 IL143862 A0 IL 143862A0 IL 14386299 A IL14386299 A IL 14386299A IL 14386299 A IL14386299 A IL 14386299A IL 143862 A0 IL143862 A0 IL 143862A0
Authority
IL
Israel
Prior art keywords
human akt
protein
medicaments
nucleic acid
acid molecule
Prior art date
Application number
IL14386299A
Other languages
English (en)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL143862A0 publication Critical patent/IL143862A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
    • C12Y207/01037—Protein kinase (2.7.1.37)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL14386299A 1998-12-22 1999-12-17 Human akt-3 IL143862A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9828375.7A GB9828375D0 (en) 1998-12-22 1998-12-22 Human akt-3
PCT/GB1999/004311 WO2000037613A2 (en) 1998-12-22 1999-12-17 Human akt-3

Publications (1)

Publication Number Publication Date
IL143862A0 true IL143862A0 (en) 2002-04-21

Family

ID=10844839

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14386299A IL143862A0 (en) 1998-12-22 1999-12-17 Human akt-3
IL143862A IL143862A (en) 1998-12-22 2001-06-20 AKT-3 of human origin, pharmaceutical preparations containing it, its uses and methods for identifying substances that affect its activity

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL143862A IL143862A (en) 1998-12-22 2001-06-20 AKT-3 of human origin, pharmaceutical preparations containing it, its uses and methods for identifying substances that affect its activity

Country Status (13)

Country Link
US (1) US7071316B1 (de)
EP (1) EP1141326B1 (de)
JP (1) JP4721205B2 (de)
AT (1) ATE293695T1 (de)
AU (1) AU774718B2 (de)
CA (1) CA2355834C (de)
DE (1) DE69924877T2 (de)
DK (1) DK1141326T3 (de)
ES (1) ES2242441T3 (de)
GB (1) GB9828375D0 (de)
IL (2) IL143862A0 (de)
NZ (1) NZ512933A (de)
WO (1) WO2000037613A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6881555B2 (en) 1999-03-19 2005-04-19 Aventis Pharmaceuticals Inc. AKT nucleic acids, polypeptides, and uses thereof
BR0009170A (pt) * 1999-03-19 2002-04-30 Aventis Pharm Prod Inc ácidos nucléicos akt, polipeptìdeos e uso dos mesmos
US6187586B1 (en) * 1999-12-29 2001-02-13 Isis Pharmaceuticals, Inc. Antisense modulation of AKT-3 expression
DE10011530A1 (de) * 2000-03-13 2001-09-27 Robert Elez Hochwirksame Antisense-Oligodesoxynucleotide gegen Polio-like Kinasel
CN1331317A (zh) * 2000-06-30 2002-01-16 上海博德基因开发有限公司 一种新的多肽——人丝氨酸/苏氨酸蛋白激酶11.22和编码这种多肽的多核苷酸
EP1195604A1 (de) * 2000-09-29 2002-04-10 Warner-Lambert Company Verfahren und Zusammensetzungen zum Screenen von Modulatoren von Lipidkinasen
WO2006022718A1 (en) * 2004-08-13 2006-03-02 Novartis Vaccines And Diagnostics Inc. Akt3 compositions and methods of use
WO2009148896A2 (en) 2008-05-29 2009-12-10 Nuclea Biotechnologies, LLC Anti-phospho-akt antibodies
JP2022524747A (ja) * 2019-03-04 2022-05-10 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア Ａｋｔ経路を標的とする神経保護遺伝子療法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0862622B1 (de) * 1995-11-16 2004-08-18 Novartis AG Methode zur Identifizierung von Verbindungen die mit RAC Proteine Kinase interagieren

Also Published As

Publication number Publication date
ES2242441T3 (es) 2005-11-01
DK1141326T3 (da) 2005-08-22
NZ512933A (en) 2003-11-28
CA2355834C (en) 2010-02-23
IL143862A (en) 2008-11-26
AU1873200A (en) 2000-07-12
EP1141326A2 (de) 2001-10-10
DE69924877D1 (en) 2005-05-25
EP1141326B1 (de) 2005-04-20
CA2355834A1 (en) 2000-06-29
DE69924877T2 (de) 2006-05-11
AU774718B2 (en) 2004-07-08
ATE293695T1 (de) 2005-05-15
JP4721205B2 (ja) 2011-07-13
WO2000037613A3 (en) 2000-11-16
US7071316B1 (en) 2006-07-04
WO2000037613A2 (en) 2000-06-29
JP2002535964A (ja) 2002-10-29
GB9828375D0 (en) 1999-02-17

Similar Documents

Publication Publication Date Title
PT910647E (pt) Variantes hiperactivas da dnase i humana
BR0009505A (pt) Compostos e processos para terapia e diagnóstico de câncer de pulmão
BR9908823A (pt) Compostos e processos para terapia e diagnóstico de câncer de pulmão
BR9907259A (pt) Compostos para terapia e diagnóstico de câncer de pulmão e processos para o seu uso
HUP0002095A2 (hu) Vegyületek prosztatarák immunterápiás kezelésére és alkalmazásuk
EE200000318A (et) Uudsed ühendid
IL136690A0 (en) Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
SI0917571T1 (en) Agouti-related gene
WO1998014596A3 (en) Disease associated protein tyrosine phosphatases
WO2002061076A1 (en) Adiponectin-associated protein
DK1025236T3 (da) Human checkpoint kinase, HCDS1, præparater og fremgangsmåde
DE69924877D1 (en) Humanes akt-3 protein
BG106008A (en) Novel lhrh antagonists with improved solubility characteristics
MXPA00006306A (es) Compuestos del canal de ion del cerebro o corazon, regulados por nucleotidos ciclicos y usos de los mismos.
IL81221A0 (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors,biotechnological methods for preparing said proteins and pharmaceutical compositions containing them
WO2003048205A3 (fr) Proteines a activite inhibitrice de l'il-6
ATE297464T1 (de) Pharmazeutische zusammensetzungen zur therapie der herzinsuffizienz
WO1998011234A3 (en) Human protein kinases
ATE312179T1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
DK1268522T3 (da) LH-RH-antagonister samt fremstilling deraf og anvendelse deraf som lægemidler
YU60199A (sh) Nove soli bpc peptida sa organo-zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena u terapiji
DE50000562D1 (de) Mittel zur behandlung von pigmentierungsstörungen
WO2001075010A3 (fr) Nouveau polypeptide, proteine humaine de transduction nucleaire 25 contenant un domaine structurel atp/gtp, et polynucleotide codant pour ce polypeptide
WO2001075050A3 (fr) Nouveau polypeptide, proteine humaine associee au transport vesiculaire 9, et polynucleotide codant pour ce polypeptide

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed